Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
Background: Mucosal melanoma (MM) is a rare but diverse cancer entity. Prognostic factors are not well established for Caucasians with MM. Patients and methods: We analysed the disease course of 444 patients from 15 German skin cancer centres. Disease progression was determined with the cumulative i...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
7 June 2017
|
| In: |
European journal of cancer
Year: 2017, Volume: 81, Pages: 36-44 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2017.05.014 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2017.05.014 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0959804917309668 
|
| Author Notes: | Markus V. Heppt, Alexander Roesch, Benjamin Weide, Ralf Gutzmer, Friedegund Meier, Carmen Loquai, Katharina C. Kähler, Anja Gesierich, Markus Meissner, Dagmar von Bubnoff, Daniela Göppner, Max Schlaak, Claudia Pföhler, Jochen Utikal, Lucie Heinzerling, Ioana Cosgarea, Jutta Engel, Renate Eckel, Alexander Martens, Laura Mirlach, Imke Satzger, Gabriele Schubert-Fritschle, Julia K. Tietze, Carola Berking |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577287223 | ||
| 003 | DE-627 | ||
| 005 | 20240316100452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180704s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2017.05.014 |2 doi | |
| 035 | |a (DE-627)1577287223 | ||
| 035 | |a (DE-576)507287223 | ||
| 035 | |a (DE-599)BSZ507287223 | ||
| 035 | |a (OCoLC)1341013310 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heppt, Markus V. |d 1987- |e VerfasserIn |0 (DE-588)1072242346 |0 (DE-627)827081111 |0 (DE-576)43371767X |4 aut | |
| 245 | 1 | 0 | |a Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma |c Markus V. Heppt, Alexander Roesch, Benjamin Weide, Ralf Gutzmer, Friedegund Meier, Carmen Loquai, Katharina C. Kähler, Anja Gesierich, Markus Meissner, Dagmar von Bubnoff, Daniela Göppner, Max Schlaak, Claudia Pföhler, Jochen Utikal, Lucie Heinzerling, Ioana Cosgarea, Jutta Engel, Renate Eckel, Alexander Martens, Laura Mirlach, Imke Satzger, Gabriele Schubert-Fritschle, Julia K. Tietze, Carola Berking |
| 264 | 1 | |c 7 June 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.07.2018 | ||
| 500 | |a Available online 7 June 2017 | ||
| 520 | |a Background: Mucosal melanoma (MM) is a rare but diverse cancer entity. Prognostic factors are not well established for Caucasians with MM. Patients and methods: We analysed the disease course of 444 patients from 15 German skin cancer centres. Disease progression was determined with the cumulative incidence function. Survival times were estimated with the Kaplan-Meier method. Prognostic parameters were identified with multivariate Cox regression analysis. Results: Common anatomic sites of primary tumours were head and neck (MMHN, 37.2%), female genital tract (MMFG, 30.4%) and anorectal region (MMAN, 21.8%). MMAN patients showed the highest vertical tumour thickness (p = 0.001), had a more advanced nodal status (p = 0.014) and a higher percentage of metastatic disease (p = 0.001) at diagnosis. Mutations of NRAS (13.8%), KIT (8.6%) and BRAF (6.4%) were evenly distributed across all tumour site groups. Local relapses were observed in 32.4% and most commonly occurred in the MMHN group (p = 0.016). Male gender (p = 0.047), advanced tumour stage (p = 0.001), nodal disease (p = 0.001) and incomplete resection status (p = 0.001) were independent risk factors for disease progression. Overall survival (OS) was highest in the MMFG group (p = 0.030) and in patients without ulceration (p = 0.004). Multivariate risk factors for OS were M stage at diagnosis (p = 0.002) and incomplete resection of the primary tumour (p = 0.001). Conclusion: In this large series of MM patients in a European population, anorectal MM was associated with the poorest prognosis. | ||
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Immune checkpoint blockade | |
| 650 | 4 | |a KIT | |
| 650 | 4 | |a Mucosal melanoma | |
| 650 | 4 | |a Staging | |
| 650 | 4 | |a Survival | |
| 650 | 4 | |a Targeted therapy | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 81(2017), Seite 36-44 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma |
| 773 | 1 | 8 | |g volume:81 |g year:2017 |g pages:36-44 |g extent:9 |a Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2017.05.014 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0959804917309668 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180704 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 14 | ||
| 999 | |a KXP-PPN1577287223 |e 3016123398 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"origin":[{"publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992"}],"pubHistory":["28.1992 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"266883400","title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"disp":"Prognostic factors and treatment outcomes in 444 patients with mucosal melanomaEuropean journal of cancer","titleAlt":[{"title":"EJC online"}],"part":{"year":"2017","volume":"81","extent":"9","text":"81(2017), Seite 36-44","pages":"36-44"}}],"origin":[{"dateIssuedDisp":"7 June 2017","dateIssuedKey":"2017"}],"recId":"1577287223","physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Markus V. Heppt, Alexander Roesch, Benjamin Weide, Ralf Gutzmer, Friedegund Meier, Carmen Loquai, Katharina C. Kähler, Anja Gesierich, Markus Meissner, Dagmar von Bubnoff, Daniela Göppner, Max Schlaak, Claudia Pföhler, Jochen Utikal, Lucie Heinzerling, Ioana Cosgarea, Jutta Engel, Renate Eckel, Alexander Martens, Laura Mirlach, Imke Satzger, Gabriele Schubert-Fritschle, Julia K. Tietze, Carola Berking"]},"person":[{"family":"Heppt","role":"aut","display":"Heppt, Markus V.","given":"Markus V."},{"given":"Jochen","display":"Utikal, Jochen","role":"aut","family":"Utikal"}],"title":[{"title_sort":"Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma","title":"Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma"}],"note":["Gesehen am 04.07.2018","Available online 7 June 2017"],"id":{"doi":["10.1016/j.ejca.2017.05.014"],"eki":["1577287223"]}} | ||
| SRT | |a HEPPTMARKUPROGNOSTIC7201 | ||